A Phase Ib/II Study of Intermittent Talazoparib Plus Temozolomide in Subjects With Metastatic Castration Resistant… https://t.co/y0gsQPSKLb
News
Recent News +++
PCCTC Investigators Drs. Rathkopf and McBride Receive Prestigious SU2C Grant
Press Releases by PCCTC October 17, 2019Award will fund novel trial using immunotherapy combined with radiation and hormone therap...
Learn MorePCCTC Germline Genetics Working Group Publishes Results
Press Releases by PCCTC July 29, 2019Study published in Clinical Genitourinary Cancer argues multidisciplinary efforts are key ...
Learn MorePCCTC Working Group Publishes Genetic Testing Manuscript
Press Releases by PCCTC April 26, 2019Investigators from the Prostate Cancer Clinical Trials Consortium (PCCTC) formed the Germl...
Learn MorePhase III DORA Study Now Enrolling Patients with mCRPC
Press Releases by PCCTC April 19, 2019The phase III DORA study (ClinicalTrials.gov Identifier: NCT03574571) led by PCCTC investi...
Learn MoreBlood Test Predicts Resistance To Hormonal Therapy
Press Releases by MedPage Today March 18, 2019AR-V7 successfully predicted resistance to hormonal therapy in advanced prostate cancer
Learn MoreClinical Implications of Genetics in Prostate Cancer
Press Releases by ASCO Daily News February 18, 2019PCCTC investigator Dr. Heather Cheng discusses future of cancer care.
Learn MoreThe PCCTC Is Expanding
Press Releases by PCCTC February 15, 2019The PCCTC is currently seeking a Quality Manager and Clinical Data Manager to join its tea...
Learn MorePCCTC Medical Director Discusses Biomarkers in Prostate Cancer
Press Releases by PCCTC December 18, 2018Dr. Michael Morris describes the need to be stratified by risk through biomarkers.
Learn MoreMovember Seeking Clinical Research Project Manager for IRONMAN Registry
Press Releases by PCCTC October 26, 2018The PCCTC serves as the the program’s Global Clinical and Data Coordination Center. ...
Learn MorePCCTC Germline Genetics Working Group Publishes White Paper
Press Releases by PCCTC August 31, 2018Manuscript published in the Journal of Clinical Oncology – Precision Oncology discus...
Learn MoreAdvocacy Symposium Led by PCCTC Investigator
Media Relations by PCCTC August 10, 2018Dr. Elisabeth Heath of Karmanos Cancer Institute will head up the 8th Annual Prostate Canc...
Learn MoreBlood Test Predicts Treatment Response, Survival in Metastatic Disease
Media Relations by PCCTC June 29, 2018PCCTC Scientific Oversight Committee Chair, Howard I. Scher, MD leads international study....
Learn MoreThe PCCTC Is Expanding Its Trial Management Capabilities
Media Relations by PCCTC June 12, 2018To better meet the needs of our partners the PCCTC is expanding its infrastructure. Our ce...
Learn MoreIRONMAN: An International Registry To Improve Outcomes in Men with Advanced Prostate Cancer
Press Releases by UroToday April 18, 2018PCCTC investigator Dr. Lorelei Mucci discusses innovative new registry initiative.
Learn MorePCCTC-Developed Apalutamide Gains FDA Approval
Press Releases by PCCTC March 9, 2018On February 14, 2018, the Food and Drug Administration (FDA) approved the next-generation ...
Learn MorePCCTC Muscadine (MPX) Study Finds Activity in Select Genotypes
Press Releases by PCCTC December 19, 2017A pre-planned subset analysis using a polymorphism of the superoxide dismutase-2 (SOD2) ge...
Learn MoreThe PCCTC Salutes Its Very Own Angie Avery
Press Releases by PCCTC November 7, 2017Celebrating Veterans Week 2017, we salute Angie Avery, PCCTC Project Coordinator.
Learn MoreTimeline of PCCTC Clinical Contributions
Press Releases by PCCTC November 6, 2017The Department of Defense (DoD) Congressionally Directed Medical Research Programs (CDMRP)...
Learn MoreEarly Development Led by the PCCTC, FDA Approval Now Sought for Apalutamide
Media Relations by Jason Harris - OncLive October 12, 2017A new drug application (NDA) has been submitted to the FDA for apalutamide (ARN-509) for t...
Learn More7th Annual Prostate Cancer Advocacy Symposium: A National Summit in Detroit
Press Releases by PCCTC September 12, 2017The 7th Annual Prostate Cancer Advocacy Symposium: A National Summit in Detroit brings tog...
Learn MoreThe PCCTC Selects Tempus as Sequencing and Analytics Provider for Phase II Clinical Trial
Press Releases by Tempus August 17, 2017Tempus, a technology company focused on helping doctors personalize cancer care by collect...
Learn MoreDr. Howard I. Scher on the Definition of Castration-Sensitive/Naive Prostate Cancer
Press Releases by UroToday August 7, 2017The PCCTC’s Scientific Oversight Committee chair speaks with UroToday at the 2017 Ad...
Learn MorePCCTC Trial Establishes Safety, Antitumor Activity of Apalutamide
Press Releases by PCCTC July 25, 2017Study represents a new standard that demonstrates the patient experience, useful for physi...
Learn MoreDr. Lorelei Mucci Discusses Innovative IRONMAN Registry
Press Releases by PCCTC July 6, 2017IRONMAN: An International Registry To Improve Outcomes in Men with Advanced Prostate Cance...
Learn MoreSignature for Aggressive-Variant CRPC Predicts Platinum Sensitivity
Press Releases by Bryant Furlow June 8, 2017PCCTC study serves as the foundation for a therapeutically relevant classification of pros...
Learn MorePCCTC Trial Results: Neoadjuvant Enzalutamide Prior to Prostatectomy
Press Releases by PCCTC May 9, 2017Study led by the University of Washington published in Clinical Cancer Research provides e...
Learn MoreThe PCCTC Is Seeking Talented Clinical Research Professionals
Press Releases by PCCTC April 24, 2017The PCCTC is currently seeking talented clinical research professionals to fill the positi...
Learn MoreDr. Taplin, Leader in Novel Targeted Therapy Development
Press Releases by PCCTC March 30, 2017The Prostate Cancer Foundation (PCF) highlights the accomplishments of PCCTC investigator ...
Learn MoreDrs. Mucci and Kantoff on Outcomes Research and IRONMAN
Press Releases by Alicia Morgans, UroToday March 23, 2017Lorelei Mucci and Phil Kantoff, MD, discuss the PCCTC-managed International Registry to Im...
Learn MorePCCTC’s Vital Role in Blood Profiling Atlas in Cancer (Blood PAC)
Press Releases by PCCTC December 20, 2016WASHINGTON, D.C. December 20, 2016 – The Breast Cancer Research Foundation (BCRF) and th...
Learn MorePCCTC Leader Discusses Future of Liquid Biopsies in Prostate Cancer
Press Releases by Gina Columbus November 22, 2016Dr. Howard I. Scher, PCCTC Scientific Oversight Committee Chair, speaks on predicting sens...
Learn MoreTeam PCCTC Joins Movember Effort
Media Relations by PCCTC November 1, 2016Prostate cancer is the second most common cancer in men worldwide. The PCCTC and Movember ...
Learn MoreThe PCCTC to Advance VP Biden’s Cancer Moonshot Goals
Press Releases by PCCTC October 27, 2016PCCTC involved with new partnership in pursuit of creating an open database for liquid ...
Learn MoreESMO 2016: PCCTC Study Benefits Men With Neuroendocrine Prostate Cancer
Press Releases by Jason Hoffman, PharmD, RPh October 10, 2016The selective aurora A kinase inhibitor Alisertib may benefit some patients with neuroend...
Learn MorePCCTC Investigator Dr. Maha Hussain Develops Prostate Cancer Advances
Press Releases by Laura Panjwani @OncEditorLaura October 4, 2016Innovative physician-scientist exemplifies research excellence while maintaining strong co...
Learn MoreFDA-Designated Breakthrough Therapy Available in PCCTC Clinical Trial
Press Releases by PCCTC August 5, 2016The US Food and Drug Administration (FDA) recently granted Novartis’ CDK4/6 inhibitor LE...
Learn MorePCCTC Facilitates Groundbreaking Prostate Cancer Gene Sequencing Study
Press Releases by PCCTC July 7, 2016Men with metastatic disease found more likely to harbor mutations in genes mediating DNA-r...
Learn MoreCDMRP Releases FY16 Clinical Consortium Research Site Award
Press Releases by PCCTC June 28, 2016The US Department of Defense (DoD) Prostate Cancer Research Program (PCRP), a division of...
Learn MorePCCTC Collaborates with Florence Healthcare to Enhance Regulatory Document Management Capabilities
Press Releases by PCCTC June 10, 2016ATLANTA, GA and NEW YORK, June 10, 2016 – Florence Healthcare, developer of the innovati...
Learn MorePCCTC Investigators Establish Guidelines for CRPC Clinical Trials
Press Releases by PCCTC May 31, 2016The latest recommendations from Prostate Cancer Working Group 3 (PCWG3) have already been...
Learn MoreVT-464, Drug in Development with PCCTC, Fast Tracked by FDA
Press Releases by WRAL TechWire January 8, 2016Innocrin’s CYP17 lyase inhibitor seviteronel (VT-464), currently in PCCTC-led early ...
Learn MoreThe PCCTC: Enabling the Practice of Precision Medicine
Press Releases by CDMRP November 24, 2015The Congressionally Directed Medical Research Programs (CDMRP) selects the PCCTC’s c...
Learn MoreThe PCCTC and Movember: Supporting Prostate Cancer Research and Awareness.
Press Releases by PCCTC November 12, 2015Over 500 investigators, and research staff from PCCTC clinical research sites have come to...
Learn MoreLandmark Trial the First to Show the Benefit of Precision Medicine in Prostate Cancer
Press Releases by The Prostate Cancer Foundation October 30, 2015Oct. 28, 2015 — A major new trial, funded in part by the Prostate Cancer Foundation ...
Learn MoreWIRB-Copernicus Group and the PCCTC Announce New Partnership
Press Releases by WIRB-Copernicus Group September 30, 2015PRINCETON, N.J. and NEW YORK, Sept. 29, 2015 /PRNewswire/ — WIRB-Copernicus Group® ...
Learn MoreStudy led by PCCTC site describes prostate cancer’s genomic landscape
Press Releases by Nicole Fawcett, University of of Michigan Comprehensive Cancer Center May 29, 2015ANN ARBOR, Mich. — An international collaboration of researchers are advancing precision...
Learn MorePCCTC Trial Demonstrates Longer Disease Control with Enzalutamide
Press Releases by PCCTC April 2, 2015SAN FRANCISCO, CA and TOKYO, JAPAN — (Marketwired) — 04/02/15 — Medivati...
Learn MoreEpic Sciences and The PCCTC Collaborate to Advance Therapeutic Development
Press Releases by PCCTC March 9, 2015SAN DIEGO – March 9, 2015 – Epic Sciences and The Prostate Cancer Clinical Trials Cons...
Learn MorePCCTC Study Shows Zytiga May Improve Outcomes When Taken Before Prostatectomy
Press Releases by PCCTC October 14, 2014To address the need for better therapies for men with high-risk localized prostate cancer,...
Learn MoreRadium Ra 223 dichloride (Xofigo Injection) FDA Approved for Castration-Resistant Prostate Cancer (CRPC)
Press Releases by PCCTC September 13, 2014On May15, 2013, the U. S. Food and Drug Administration (FDA) approved radium Ra 223 dichlo...
Learn MoreRFA: PCCTC Affiliate Clinical Research Sites
Press Releases by PCCTC July 22, 2014The PCCTC is now accepting applications for its Affiliate Clinical Research Site program. ...
Learn MorePCCTC Trial Shows Tasquinimod Prolongs Survival in Metastatic Prostate Cancer
Press Releases by PCCTC November 22, 2013Survival data from a phase II PCCTC trial of single agent tasquinimod (NCT00560482) furthe...
Learn MoreNew Test Differentiates Low- and High-Risk Prostate Cancer
Press Releases by PCCTC May 9, 2013Genomic Health, Inc. announced the launch of its Oncotype DX® prostate cancer test whic...
Learn MoreFDA Approves Abiraterone acetate (Zytiga) For Second Indication
Press Releases by PCCTC December 11, 2012On December 10, 2012, the U. S. Food and Drug Administration (FDA) approved an expanded i...
Learn MoreView More News +
Follow Us
Multi-arm Multi-modality Therapy for Very High Risk Localized and Low Volume Metastatic Prostatic Adenocarcinoma (N… https://t.co/HINX1wZHaR
Join our team of dedicated clinical research professionals! The Prostate Cancer Clinical Trials Consortium is currently seeking a Quality Manager and Clinical Data Manager to help fulfill our…
2018-23944 Clinical Data Manager, Prostate Cancer Clinical Trials Consortium (PCCTC) | Memorial Sloan Kettering Cancer Center Careers
careers.mskcc.org
Committed to world-class science!
Our services translate scientific discoveries into improved standards of care, ensuring efficient trial selection, reporting, site management, clinical operations and data analyses.